Jennifer Kan
General Partner at Juniper
About
Jennifer Kan, a PhD bioengineer whose enzyme engineering was noted in the 2018 Nobel lecture, co-founded a climate biotech spin-out focused on engineered biology and holds patents in biocatalysis.
Invests in
Biotech